Shanghai Epiprobe Biotechnology Co., Ltd.
PrivateLast Round
Series B
Apr 11, 2022
Total Funding Raised
$15.7M
Company Overview
Shanghai Epiprobe Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in April 2022.
Shanghai Epiprobe Biotechnology Co., Ltd. is a biotechnology company that develops molecular diagnostic products for cancer DNA methylation and precision theranostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Epiprobe Biotechnology Co., Ltd. Comparables
Compare Shanghai Epiprobe Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing OriginPoly Bio-Tec Co., Ltd. | 86% | |
| Creative Biosciences (Guangzhou) Co., Ltd. | 82% | |
| Wuhan KadWise Biotechnology Co., Ltd. | 81% |
For institutional investors. Book with your work email.
Shanghai Epiprobe Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 11, 2022 | ||||
| Series A | Nov 1, 2020 | ||||
| Pre Seed | Aug 1, 2020 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 11, 2022
$16M round with Dian Diagnostics Group and Tianjin Yiyi Hygiene Products Co Ltd.
- Aug 1, 2020
Completed a Pre Seed funding round.
For institutional investors. Book with your work email.
Shanghai Epiprobe Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Epiprobe Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Epiprobe Biotechnology Co., Ltd. a public or private company?
Shanghai Epiprobe Biotechnology Co., Ltd. is a private company.
What is the current stock price of Shanghai Epiprobe Biotechnology Co., Ltd.?
Shanghai Epiprobe Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Epiprobe Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Epiprobe Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Epiprobe Biotechnology Co., Ltd. is not publicly available.
Can I buy Shanghai Epiprobe Biotechnology Co., Ltd. stock?
Shanghai Epiprobe Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Epiprobe Biotechnology Co., Ltd.'s last funding round?
Shanghai Epiprobe Biotechnology Co., Ltd.'s most recent funding round was Series B on April 11, 2022.
Who are the main investors in Shanghai Epiprobe Biotechnology Co., Ltd.?
Investor information for Shanghai Epiprobe Biotechnology Co., Ltd. is not publicly disclosed.
Will Shanghai Epiprobe Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Epiprobe Biotechnology Co., Ltd..
How can I track Shanghai Epiprobe Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Epiprobe Biotechnology Co., Ltd.'s shares on secondary markets.